Services on Demand
- Cited by SciELO
- Access statistics
Revista Brasileira de Hematologia e Hemoterapia
Print version ISSN 1516-8484On-line version ISSN 1806-0870
GODOY, José M. P. de et al. Amnaphtone in the treatment of nosebleed. Rev. Bras. Hematol. Hemoter. [online]. 2003, vol.25, n.1, pp.65-66. ISSN 1516-8484. http://dx.doi.org/10.1590/S1516-84842003000100010.
Nasal haemorrhage or nosebleed, is the most common of haemorrhages due to the intense vasculization of the nose, the fragility of the nasal mucous membrane and its vulnerability to traumas and irritant agents. The aim of this study is to report on a reduction of episodes of nosebleed in two patients with the use of amnophtone. A 34-year-old male patient and a 44- year-old female patient presented with histories of two or more nosebleeds per week, despite treatment during the acute phase. They both sought medical assistance for other vascular complaints, which were suggestive of vascular insufficiency as, during the physical examination petechia lesions in the lower limbs were detected. They were treated with 75 mg of amnaphtone three times daily. One week after, at the follow-up, they reported an improvement of the vascular symptoms, however, more markedly was the significant improvement in relation to the nosebleeds which were frequent but had not been reported in the first consultation. In conclusion, amnaphtone demonstrated to be efficient in the prevention of recurrence of nosebleed in these patients.
Keywords : nosebleed; aminophtone; improvement.